Abstract
Abstract The aberrant Wnt/β-catenin signaling pathway facilitates cancer stem cell renewal, cell proliferation and differentiation, thus exerting crucial roles in tumorigenesis and therapy response. Accumulated investigations highlight the therapeutic potential of agents targeting Wnt/β-catenin signaling in cancer. Wnt ligand/ receptor interface, β-catenin destruction complex and TCF/β-catenin transcription complex are key components of the cascade and have been targeted with interventions in preclinical and clinical evaluations. This scoping review aims at outlining the latest progress on the current approaches and perspectives of Wnt/β-catenin signaling pathway targeted therapy in various cancer types. Better understanding of the updates on the inhibitors, antagonists and activators of Wnt/β-catenin pathway rationalizes innovative strategies for personalized cancer treatment. Further investigations are warranted to confirm precise and secure targeted agents and achieve optimal use with clinical benefits in malignant diseases.
Keywords
Wnt signaling pathwayCateninCancer researchCarcinogenesisCancerMedicineCancer stem cellTargeted therapySignal transductionBioinformaticsBiologyInternal medicineCell biology
Affiliated Institutions
Related Publications
Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium
The HMG-box transcription factor Sox9 is expressed in the intestinal epithelium, specifically, in stem/progenitor cells and in Paneth cells. Sox9 expression requires an active β...
β-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion
ABSTRACT We found that cultured human keratinocytes with high proliferative potential, the putative epidermal stem cells, expressed a higher level of noncadherin-associated β- c...
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signal...
Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells
Abstract The epithelial components of the mammary gland are thought to arise from stem cells with a capacity for self-renewal and multilineage differentiation. Furthermore, thes...
Wilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling
Aberrant WNT signal transduction is involved in many diseases. In colorectal cancer and melanoma, mutational disruption of proteins involved in the degradation of β-catenin, the...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 13
- Issue
- 1
- Pages
- 165-165
- Citations
- 1329
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1329
OpenAlex
Cite This
Ya Zhang,
Xin Wang
(2020).
Targeting the Wnt/β-catenin signaling pathway in cancer.
Journal of Hematology & Oncology
, 13
(1)
, 165-165.
https://doi.org/10.1186/s13045-020-00990-3
Identifiers
- DOI
- 10.1186/s13045-020-00990-3